Novavax (US) has named Frederick Driscoll vice-president, chief financial officer and treasurer. He was previously chief financial officer, president and chief executive officer of Genelabs Technologies. Before that, Mr Driscoll served in several financial and senior management positions at Astraris, OXiGENE and Collagenesis.

Genyx Medical Inc.'s initial product, Uryx, is a permanent urethral bulking agent for, for example, coughing or laughing.

Incontinence represents a significant unmet medical need for 20 million Americans that suffer from urge incontinence, and 13 million sufferers of stress incontinence. The market is large, growing, and approachable for small device companies--if they can get funding, that is.